Agyl AI, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Agyl AI, Inc. - overview
Established
2022
Location
Nashville, TN, US
Primary Industry
Medical Devices & Equipment
About
Agyl AI is an artificial intelligence company that provides innovative solutions designed to enhance productivity for businesses across various sectors, leveraging advanced technology to address complex challenges. Agyl AI, Inc. specializes in artificial intelligence solutions, focusing on data-driven platforms to help businesses optimize their operations. The company, founded in 2022 and headquartered in Nashville, US, has completed one deal as of August 2025, raising a total of USD 2.
00 mn in funding during its latest round. The company's founder has a history of entrepreneurial ventures, although specific details about prior companies are not available. AGYL AI specializes in advanced AI solutions tailored for both emerging and enterprise-level organizations facing complex business challenges. The company's core product offerings include EKOM™, a data science-driven platform that integrates intelligent automation to transform static content into dynamic storefronts that enhance revenue generation.
Another key offering is Writerly®, a no-code SaaS platform designed to streamline productivity across sales operations, marketing, and long-form content creation. AGYL Labs serves as the collaborative arm of the company, partnering with leading firms and institutions to innovate and deliver unique solutions that cater to a diverse client base spanning North America, Europe, and Asia. AGYL AI generates revenue primarily through subscription-based models and partnerships that facilitate the integrated use of its flagship products, EKOM™ and Writerly®. Clients engage with the company on a B2B basis, accessing the solutions via structured agreements that may involve tiered pricing plans based on the level of service or features required.
Subscriptions may cover various functionalities, allowing businesses to scale their use of the platforms according to their specific operational needs. This transactional structure fosters long-term relationships with clients and ensures a steady revenue stream as customers leverage AGYL AI's tools to enhance productivity and drive growth. Agyl AI plans to launch new product features and enhancements for EKOM™ and Writerly® by mid-2026, addressing the evolving needs of its clients. The company is also targeting expansion into the Asia-Pacific region by the end of 2026, aiming to establish a stronger presence in rapidly growing markets.
The recent USD 2 million venture funding raised in August 2025 will be utilized to support these initiatives, including product development and market entry strategies.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.agyl.ai/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.